GELS
Price
$0.42Alerts
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
Capitalization
4.72M
Intraday BUY SELL Signals
IRWD
Price
$4.87Alerts
Change
+$0.06 (+1.25%)
Updated
Nov 11 closing price
Capitalization
725.4M
99 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GELS vs IRWD

GELS vs IRWD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GELS vs. IRWD commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GELS is a StrongBuy and IRWD is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for GELS with price predictions
Nov 10, 2026

GELS's Stochastic Oscillator is remaining in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GELS's RSI Indicator exited the oversold zone, 14 of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for GELS just turned positive on October 27, 2026. Looking at past instances where GELS's MACD turned positive, the stock continued to rise in 16 of 19 cases over the following month. The odds of a continued upward trend are 84%.

Following a +3.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where GELS advanced for three days, in 51 of 64 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GELS as a result. In 35 of 36 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GELS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

GELS broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GELS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.589) is normal, around the industry mean (6.379). P/E Ratio (-1.236) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (52.632) is also within normal values, averaging (183.387).

The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. GELS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GELS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for IRWD with price predictions
Nov 10, 2026

IRWD's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for IRWD turned positive on October 28, 2026. Looking at past instances where IRWD's MACD turned positive, the stock continued to rise in 36 of 45 cases over the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on IRWD as a result. In 77 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

IRWD moved above its 50-day moving average on November 05, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IRWD crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

Following a +9.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRWD advanced for three days, in 181 of 263 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 50-day moving average for IRWD moved below the 200-day moving average on October 27, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRWD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

IRWD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IRWD entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.482) is normal, around the industry mean (6.379). P/E Ratio (5.488) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (1.780) is also within normal values, averaging (183.387).

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. IRWD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRWD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
IRWD: Fundamental Ratings
IRWD
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GELSIRWD
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 2 days ago
69%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 10 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (GELS: $0.42 vs. IRWD: $4.81)
Brand notoriety: GELS and IRWD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GELS: 2% vs. IRWD: 199%
Market capitalization -- GELS: $4.72M vs. IRWD: $725.4M
GELS [@Pharmaceuticals: Generic] is valued at $4.72M. IRWD’s [@Pharmaceuticals: Generic] market capitalization is $725.4M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GELS’s FA Score shows that 2 FA rating(s) are green while IRWD’s FA Score has 1 green FA rating(s).

  • GELS’s FA Score: 2 green, 3 red.
  • IRWD’s FA Score: 1 green, 4 red.
According to our system of comparison, both GELS and IRWD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GELS’s TA Score shows that 4 TA indicator(s) are bullish while IRWD’s TA Score has 5 bullish TA indicator(s).

  • GELS’s TA Score: 4 bullish, 4 bearish.
  • IRWD’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, GELS is a better buy in the short-term than IRWD.

Price Growth

GELS (@Pharmaceuticals: Generic) experienced а -14.09% price change this week, while IRWD (@Pharmaceuticals: Generic) price change was +37.43% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.

Reported Earning Dates

IRWD is expected to report earnings on Feb 18, 2027.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.20% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
Interact to see
Advertisement

GELS and

Correlation & Price change

A.I.dvisor tells us that GELS and SXTC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GELS and SXTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GELS
1D Price
Change %
GELS100%
-6.12%
SXTC - GELS
25%
Poorly correlated
-7.10%
HCM - GELS
24%
Poorly correlated
+0.39%
AMLX - GELS
23%
Poorly correlated
+2.32%
IRWD - GELS
23%
Poorly correlated
+2.78%
EVO - GELS
22%
Poorly correlated
-2.87%
More

IRWD and

Correlation & Price change

A.I.dvisor tells us that IRWD and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
+2.78%
ACET - IRWD
30%
Poorly correlated
+0.33%
PRGO - IRWD
29%
Poorly correlated
-0.71%
IXHL - IRWD
25%
Poorly correlated
-8.22%
TLRY - IRWD
24%
Poorly correlated
-7.02%
PAHC - IRWD
24%
Poorly correlated
+0.09%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NCDL11.91-0.01
-0.08%
Nuveen Churchill Direct Lending Corp
SHOO42.53-0.31
-0.72%
Steven Madden Ltd
JHX29.05-0.89
-2.97%
JAMES HARDIE INDUSTRIES plc
NVNO6.45-0.40
-5.84%
enVVeno Medical Corporation
HURA1.51-0.15
-9.04%
TuHURA Biosciences Inc